Larvol Delta - Evaluationn-of-Tolerability-and-Safety-of-CBT101-an-Autologous-Natural-Killer-Cell-in-Patients-With-Solid-Cancer

bozitinib (APL-101) - Apollomics

CBT101 - CHA Bio & Diostech

http://clinicaltrials.gov/ct2/show/NCT04557306

Feb 7, 2024

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next